Yx. Pan et al., CLONING AND FUNCTIONAL-CHARACTERIZATION THROUGH ANTISENSE MAPPING OF A KAPPA(3)-RELATED OPIOID RECEPTOR, Molecular pharmacology, 47(6), 1995, pp. 1180-1188
We have identified a putative opioid receptor from mouse brain (KOR-3)
, belonging to the G protein-coupled receptor family, that is distinct
from the previously cloned mu, delta, and kappa(1) receptors. Assignm
ent of the clone to the opioid receptor family derives from both struc
tural and functional studies. Its predicted amino acid sequence is hig
hly homologous to that of the other opioid receptors, particularly in
many of the transmembrane regions, where long stretches are identical
to mu, delta, and kappa(1) receptors. Both cyclazocine and nalorphine
inhibit cAMP accumulation in COS-7 cells stably expressing the clone.
Northern analysis shows that the mRNA is present in brain but not in a
number of other organs. Southern analysis suggests a single gene enco
ding the receptor. A highly selective monoclonal antibody directed aga
inst the native kappa(3) receptor recognizes, in Western analysis, the
clone expressed in COS-7 cells. The in vitro translation product is a
lso labeled by the antibody. Additional clones reveal the presence of
several introns, including one in the second extracellular loop and an
other in the first transmembrane region. Antisense studies with an oli
godeoxynucleotide directed against a region of the second extracellula
r loop reveal a selective blockade of kappa(3) analgesia in vivo that
is not observed with a mismatch oligodeoxynucleotide based upon the an
tisense sequence. The mu, delta, and kappa(1) analgesia is unaffected
by this antisense treatment. Antisense mapping of the clone downstream
from the splice site in the first transmembrane region reveals that s
ix different antisense oligodeoxynucleotides all block kappa(3) analge
sia. In contrast, only one of an additional six different antisense ol
igodeoxynucleotides directed at regions upstream from this splice site
is effective. This strong demarcation between the two regions raises
the possibility of splice variants of the receptor. An additional clon
e reveals an insert in the 3' untranslated region. In conclusion, the
antibody and antisense studies strongly associate KOR-3 with the kappa
(3)-opioid receptor, although it is not clear whether it is the kappa(
3) receptor itself or a splice variant.